No more shocks? Study shows drug treatment for major depression just as effective as electroconvulsive therapy

By Gretchen Cuda Kroen: Complete Post through this link…

The anesthetic drug ketamine is at least as effective as electroconvulsive therapy for treating major depression and has fewer side effects, a study published Wednesday in the New England Journal of Medicine reported.

More than 21 million adults in the US are estimated to suffer from Major Depressive Disorder. For those whose depression fails to respond to anti-depressive drugs, ECT, which involves inducing a seizure via electrical stimulation of the brain, is one of the few treatments that can provide life-changing relief.

The clinical trial of 403 patientsis the largest study ever done comparing ketamine and ECT treatments for depression that has ever been done, and the only one that also measured impacts to memory, Anand said.

The trial, conducted overfiveyears across multiple institutions including the Cleveland Clinic, compared the outcomes of patients selected at random to either receive ECT three times per week or ketamine twice per week for three weeks. Following treatment, patients answered questions about their depressive symptoms and quality of life, along with a battery of memory tests for the next six months.

Investigators found that 55% of patients who received ketamine and 41% who received ECT reported at least a 50% improvement in their self-reported depressive symptoms and quality of life that lasted at least six-months and concluded that treatments with ketamine were as effective as ECT.

Polypharmacy Killed My Son. He’s Not Alone

BY ANDREA SONNENBERG: Complete Post through this link…

Five years ago, my 21-year-old son Bradley died of psychiatric drug interactions, after years of battling anxiety, depression, and an eating disorder. In most respects, Bradley was very much like many kids you know. He was funny, smart, and talented, constantly making people laugh with goofy impersonations, and starring in school plays and musicals. We—me, my husband, and Bradley’s siblings—deeply supported him in his challenges with mental health. He had access to the best healthcare available. But despite his privilege, we couldn’t save him.

At the time of his death, Bradley was taking a cocktail of medications prescribed by respected doctors. Bradley died unexpectedly in his sleep because of a practice called polypharmacy—the layering of multiple medications on top of one another, often without regard to what other doctors have already prescribed or the potential interactions between the drugs.

It is not uncommon for patients to receive psychiatric medication without being evaluated by a mental-health professional. Often, a primary-care physician will prescribe an antidepressant without considering various other evidence-based treatments that may be more effective and without possible side effects. There are also the financial incentives, whereby insurance companies are more inclined to pay for medications than therapy, and at a higher reimbursement rate. That’s not to say that medications can’t be helpful; often they are critical to treatment and produce miraculous results. But many medications come with serious side effects. When many medications are taken together, they can cause harmful drug interactions. Plus, there is the risk of taking the wrong dosage, either too high or too low, which can lead to potential withdrawal symptoms or accidental overdose.

Chronic Pain Incidence Is High in the U.S.

by Judy George: Complete Post through this link…

New cases occur more frequently than other conditions, and often persist.

New cases of chronic pain — defined as pain experienced on most days or every day over 3 months — occurred more frequently than new cases of other common chronic conditions, U.S. survey data showed.

Chronic pain incidence was 52.4 cases per 1,000 person-years, reported Richard Nahin, MPH, PhD, of the NIH in Bethesda, Maryland, and co-authors.

This was higher than the incidence of diabetes (7.1 cases/1,000 person-years), depression (15.9 cases), and hypertension (45.3 cases), the researchers said in JAMA Network Openopens in a new tab or window.

Moreover, chronic pain was persistent: nearly two-thirds (61.4%) of adults with chronic pain in 2019 continued to have it in 2020.

The findings come from National Health Interview Survey (NHISopens in a new tab or window) data and are the first nationwide estimates of chronic pain incidence.

Recent NHIS data showed the prevalence of chronic painopens in a new tab or window in the U.S. was about 21%, affecting an estimated 51.6 million adults. High-impact chronic pain — pain severe enough to restrict daily activities — affected 17.1 million people.

“Understanding incidence, beyond overall prevalence, is critical to understanding how chronic pain manifests and evolves over time,” Nahin said in a statement. “These data on pain progression stress the need for increased use of multimodal, multidisciplinary interventions able to change the course of pain and improve outcomes for people.”

BREAKING NEWS: Medicare Covers Seat Elevation for Medicare Beneficiaries using Power Wheelchairs

From Independence Through Enhancement: Complete Post through this link…

We are thrilled to announce that CMS decided to cover seat elevation in all power wheelchairs for the purposes of performing all transfers or to improve reach in performing mobility related activities of daily living (MRADLs) in their homes. This is a major expansion of coverage from the preliminary coverage decision announced in mid-February and CMS attributed these coverage improvements to the 2,130 public comments received by wheelchair users, advocates, clinicians, and researchers. The final seat elevation Decision Memo can be viewed HERE.

For the first time, CMS determined that seat elevation in power wheelchairs is considered “primarily medical in nature” and is, therefore, covered durable medical equipment (DME) under both traditional Medicare and Medicare Advantage. Seat elevation will be covered in Groups 2, 3 and 5 Complex Rehabilitative Technology (CRT) power wheelchairs when a patient needs seat elevation to transfer from one surface to another, with or without caregiver assistance, assistive devices, or lift equipment or to improve one’s reach in order to perform MRADLs. Seat elevation will also be covered in non-CRT power wheelchairs when determined by Medicare contractors to be reasonable and necessary.  Individuals must undergo a specialty evaluation performed by a licensed/certified medical professional who has specific training and experience in rehabilitative wheelchair evaluations.

This decision is effective immediately but CMS will consider new coding and payment determinations in the future. Beneficiaries who are most likely to benefit from this decision include people with Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, spinal cord injury, paralysis, ALS, limb amputation, Lupus, rheumatoid arthritis, myositis, and other mobility-related conditions.

‘A System in Crisis’: Dysfunctional Federal Disability Programs force the Poor to pass up money

By Fred Clasen-Kelly: Complete Post through this link…

Brenda Powell had suffered a stroke and was in debilitating pain when she called the Social Security Administration last year to seek disability benefits.

The former Louisiana state office worker struggled at times to write her name or carry a glass of water. Powell, then 62, believed she could no longer work, and she was worried about how to pay for medical care with only a $433 monthly pension.

Although the Social Security Administration agreed that Powell’s condition limited the work she could do, the agency rejected her initial application for Supplemental Security Income. She had the choice to appeal that decision, which could take months or years to resolve, or take early retirement. The latter option would give her $302 a month now but might permanently reduce the full Social Security retirement payment she would be eligible for at age 66 and 10 months.

“I didn’t know what to do. These decisions are not easy,” said Powell, who lives in Alexandria, Louisiana, about 200 miles northwest of New Orleans. She decided to appeal the decision but take early retirement in the meantime.

“I had to have more money to pay my bills,” she said. “I had nothing left over for gas.”

Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune

By Samuel M. Goldman. et al.: Complete Post through this link…

Key Points

Question  Is Parkinson disease risk increased in military service members who were stationed at Marine Corps Base Camp Lejeune, North Carolina, during 1975-1985 when the water supply was contaminated with trichloroethylene and other volatile organic compounds?

Findings  This cohort study of 340 489 service members found that the risk of Parkinson disease was 70% higher in Camp Lejeune veterans compared with veterans stationed at a Marine Corps base where water was not contaminated. In veterans without Parkinson disease, risk was also significantly higher for several prodromal features of Parkinson disease.

Meaning  The study’s findings suggest that exposure to trichloroethylene in water may increase the risk of Parkinson disease; millions worldwide have been and continue to be exposed to this ubiquitous environmental contaminant.

Why Lyme disease symptoms go away quickly for some and last years for others

By Caroline Hopkins: Complete Post through this link…

Why some people recover from Lyme disease, while others experience months, years or even decades of chronic symptoms has long puzzled doctors. New research offers some clues to an immune system marker in the blood that is elevated among people with lingering Lyme disease symptoms, even after they’d received antibiotics. 

In the new study, published on May 9 in the Center for Disease Control and Prevention’s Emerging Infectious Diseases journal, researchers found an immune system marker in the blood called interferon-alpha was elevated among people who had been treated for Lyme disease but had lingering symptoms.

Interferon-alpha is one of a handful of key signaling proteins the body makes to tell immune cells to fight off bacteria or viruses. If the blood levels are too high, the immune system can overact, causing pain, swelling and fatigue — symptoms often seen with Lyme disease.

In patients with high levels of interferon-alpha, the immune response to the Lyme bacteria may cause chronic inflammation, even once the infection is gone, said Klemen Strle, an assistant research professor of molecular biology and microbiology at Tufts University and an author of the new study. 

Non-Invasive Brain Imaging Deciphers Hand Gestures

From Neuroscience News: Complete Post through this link…

Summary: Researchers have developed a non-invasive method to identify hand gestures through brain imaging.

The technique utilizes magnetoencephalography (MEG) and could contribute to the evolution of brain-computer interfaces. Such interfaces could help individuals with physical challenges, like paralysis or amputated limbs, to control supportive devices using their minds.

This work represents the most successful non-invasive single-hand gesture differentiation achieved to date.

Key Facts:

  1. The researchers successfully used non-invasive MEG to distinguish different hand gestures with over 85% accuracy.
  2. The technique, which is as safe as taking a patient’s temperature, has potential applications for those with physical challenges.
  3. MEG measurements from only half of the brain regions sampled yielded nearly comparable results, suggesting future MEG helmets might require fewer sensors.

Brain Activity Reveals Chronic Pain Signatures

From Neuroscience News: Complete Post through this link…

Summary: Researchers successfully recorded data directly from the brains of individuals suffering from chronic pain caused by stroke or amputation. This milestone, accomplished using machine learning tools, identified specific brain regions and biomarkers associated with chronic pain.

The findings mark a significant stride towards devising novel methods for monitoring and treating chronic pain. This research is expected to inform future deep brain stimulation (DBS) therapies and guide the search for non-addictive chronic pain treatments.

Key Facts:

  1. This is the first study to record chronic pain-related data directly from the brain, identifying an area of the brain associated with chronic pain.
  2. The researchers utilized machine learning tools to analyze the recorded data, offering new insights into the brain’s representation of pain.
  3. The findings are expected to guide future therapies, particularly deep brain stimulation (DBS), and contribute to the development of non-addictive treatments for chronic pain.

Psychiatric Detentions Rise 120% in First Year of 988

By Rob Wipond: Complete Post through this link…

As contacts to the new 988 hotline number have risen, so have call tracing and police interventions.

The rapid growth of the new 988 mental health hotline has been greeted with positive media coverage. As many people expected, calls, texts, and chats to the National Suicide Prevention Lifeline, now renamed “988 Suicide and Crisis Lifeline,” started climbing immediately with the launch of the 988 number in July of 2022. The Substance Abuse and Mental Health Services Administration (SAMHSA) and the nonprofit that was given centralized control over the 988 system, Vibrant Emotional Health (VEH), have been releasing monthly updates on key metrics.

In April 2023, compared to April 2022, calls answered increased by 52%, chats by 90%, and texts by 1022%. The trend was heralded by federal Health and Human Services Secretary Xavier Becerra to CNN: “Our nation’s transition to 988 moves us closer to better serving the crisis care needs of people across America. 988 is more than a number, it’s a message: we’re there for you.”

However, as previously reported by Mad in America, a percentage of people who contacted the former National Suicide Prevention Lifeline were subjected to geolocation tracing of their phone, computer, or mobile device. The Lifeline advertised itself as a place for confidential discussions about suicidal feelings but, according to its own policy, if a call-attendant believed a person might be at “imminent risk” of taking their own life in the next few hours, days, or week, the call-attendant was required to contact 911 or a Public Safety Answering Point to send out police and/or an ambulance to forcibly take the person to a psychiatric hospital.

Many Lifeline users described the experiences of betrayal, public exposure, police interactions, loss of freedoms, and forced psychiatric treatment as dangerous, harmful and traumatizing.

So, since the transition to 988, has anything changed? As contacts to 988 rise, how many people are getting forcibly subjected to these types of unexpected, unwanted interventions?

It appears detention numbers are climbing dramatically, too—even as VEH, SAMHSA, and many news outlets continue to obfuscate the facts publicly.

Contacts and Detentions Rising Together

For the ten-month period from July 2022 to April 2023, the new 988 Lifeline received more than 4 million total contacts—on pace to double the average 2.4 million calls annually to the Lifeline from 2017 to 2021.

The 988 metrics that are publicly shared, though, do not include any information about call tracing and involuntary interventions.